Drugs & Targets FDA grants priority review to MCNA in certain bladder cancer patients October 30, 2015Vol.41 No.40
Drugs & Targets Imlygic Approved as First U.S. Oncolytic Viral Cancer Therapy October 30, 2015Vol.41 No.40
A Third of Hospitals Will Drop Out of 340B if HRSA Enacts New Guidance, Survey Finds October 30, 2015Vol.41 No.40By Matthew Bin Han Ong
Capitol Hill Budget Deal Eases Sequestration, Includes Medicare Site Neutrality October 30, 2015Vol.41 No.40By Conor Hale
Conversation with The Cancer Letter Lilly’s PACE Continuous Innovation Indicators Visualize Progress and Value in Research October 30, 2015Vol.41 No.40By Matthew Bin Han Ong
